Morphic Medical
The conference has been instigated and organised by ABCD. Sponsors have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated.
THE WORLD’S FIRST MEDICAL DEVICE DESIGNED TO TARGET THE UNDERLYING CAUSE OF OBESITY AND TYPE 2 DIABETES. Since Morphic Medical’s founding in 2003, our mission has been to alleviate the symptoms of obesity and type 2 diabetes for patients fighting these global epidemics worldwide. Our revolutionary RESET® therapy is a testament to Morphic Medical’s mission. The first endoscopically delivered device therapy for the treatment of obesity and type 2 diabetes. Morphic Medical’s aim is to bridge the gap between pharmaceuticals and surgery by providing an alternate treatment option to help reduce HbA1c and weight for individuals who are underserved by drugs and injections, but for whom surgery may not be an option. Morphic Medical is headquartered in Boston, Massachusetts. Our team of business experts and industry veterans have a successful track record of pioneering and commercializing breakthrough healthcare technologies.
